Other
Newborns
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
Newborns is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
16
clinical trials
Completed12 · 75%
Unknown status2 · 13%
Terminated1 · 6%
Withdrawn1 · 6%
Clinical Trials
Trial Activity
16 trials
Intraoral 30% Glucose Effect In Newborns
Completed·—·Phase 3·NCT02325583·19 enrolled
Effect of Banana Blossom on Breast Milk Volume in Mothers of Preterm Newborns
Completed·—·Phase 4·NCT05465460·70 enrolled
Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns
Completed·—·Phase 2·NCT01605279·127 enrolled
Antiretroviral Regime for Viral Eradication in Newborns
Completed·NNational Center for Women and Children's Health, China CDC·Phase 4·NCT02712801·600 enrolled
Pharmacokinetics of Oseltamivir in Newborns and Infants
Completed·—·N/A·NCT01388439·19 enrolled
L-Thyroxine Supplementation for Preterm Newborns Less Than 32 Weeks of Gestation With Hypothyroxinemia
Completed·—·Phase 3·NCT01306227·50 enrolled
Early Administration of the Lutein/Zeaxanthin in Premature Newborns
Withdrawn·—·N/A·NCT03340103
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)